Elironrasib

· Revolution Medicines, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Elironrasib, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors [Phase 1, Phase 2]

See pricing